GRDN
Strong BuyPremium GrowerFLAGGuardian Pharmacy Services, Inc. · Healthcare · United States · $2.3B · Avg Vol: $27M/d
Premium Grower: Strong business with the market behind it, but you are paying up for it.
Guardian Pharmacy has strong quality at Q82 and M79, but value at V28 is far below the calibrated floor. Institutional pharmacy services at a full valuation with no corroborating filing.
The ranks quoted here are from the day it was written; today's Quality, Value and Momentum are the bars above.
ABOUT GUARDIAN PHARMACY SERVICES, INC.
Read
Guardian Pharmacy Services, Inc. is one of the largest long-term care (LTC) pharmacy operators in the United States, serving assisted living and skilled nursing facilities. The company's competitive moat is its decentralized business model, which combines local pharmacy autonomy and customer service with corporate-level purchasing power and technology. It operates as a leading institutional healthcare services provider.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 908.9M | 1.0B | 1.2B | 1.4B | 16.8% | 1.5B | 1.4B | 1.5B | 3.0% |
| EPS | 0.58 | 0.00 | -1.77 | 0.79 | 10.7% | 1.04 | 0.96 | 1.06 | 15.6% |
| Shares | 60.8M | 60.8M | 63.3M | 63.3M | +4.1% | 49.8M | — | — | — |
| Debt | 56.8M | 61.0M | 30.1M | 37.1M | -13.2% | 39.3M | — | — | — |
| Equity | 0 | 0 | 142.7M | 205.8M | 44.2% | — | — | — | — |
| Op CF | 48.5M | 70.8M | 58.0M | 100.3M | 27.4% | 98.9M | — | — | — |
| Inv CF | -17.9M | -13.4M | -30.4M | -32.2M | — | — | — | — | — |
| Fin CF | -45.0M | -57.2M | -23.6M | -7.1M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of GRDN are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| GRDN | Guardian Pharmacy Services, Inc.(you) | $2.3B | 88 | Strong Buy |
| ADUS | Addus HomeCare Corporation | $2.2B | 92 | Strong Buy |
| ASTH | Astrana Health, Inc. | $1.9B | 83 | Strong Buy |
| MD | Pediatrix Medical Group, Inc. | $2.2B | 97 | Strong Buy |
| ARDT | Ardent Health, Inc. | $1.5B | 91 | Strong Buy |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.9B | 95 | Strong Buy |
| NHC | National HealthCare Corporation | $3.5B | 92 | Strong Buy |
| HCSG | Healthcare Services Group, Inc. | $1.5B | 94 | Strong Buy |
| CON | Concentra Group Holdings Parent, Inc. | $4.4B | 91 | Strong Buy |
| AMN | AMN Healthcare Services, Inc. | $1.3B | 96 | Strong Buy |
Peer medians: ROE -31.0% · P/E 25.0x · Gross margin 58.3%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.